Patents by Inventor Guangbin Xia

Guangbin Xia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genome Edited iPSC-Derived Monocytes Expressing Trophic Factors
    Publication number: 20200377856
    Abstract: Trophic factor expressing monocyte cells derived from gene-edited induced pluripotent stem cells, methods for making and using.
    Type: Application
    Filed: November 16, 2018
    Publication date: December 3, 2020
    Applicant: STC.UNM
    Inventor: Guangbin Xia
  • Therapy For Myotonic Dystrophy Type 1 Via Genome Editing of the DMPK Gene
    Publication number: 20200353010
    Abstract: Methods and mechanisms for treating and/or alleviating myotonic dystrophy type 1 (DM1 by editing the DMPK gene. Editing of the DMPK gene may take place in vivo, or may involve ex vivo correction followed by implantation of genome-corrected cells.
    Type: Application
    Filed: November 16, 2018
    Publication date: November 12, 2020
    Applicant: STC.UNM
    Inventor: Guangbin Xia